Phase II study of efficacy of bevacizumab plus chemotherapy in management of malignant pleural effusion in non-squamous non-small cell lung cancer patients with malignant pleural effusion (MPE) unsuccessfully controlled by tube drainage or pleurodesis (NEJ-13-2 trial)

被引：0
|
作者：
Noro, R. [1 ]
Kobayashi, K. [2 ]
Usuki, J. [3 ]
Hosomi, Y. [4 ]
Nishitsuji, M. [5 ]
Okamoto, H. [6 ]
Ando, M. [7 ]
Hino, M. [8 ,9 ,10 ]
Hagiwara, K. [11 ]
Miyanaga, A. [1 ]
Seike, M. [1 ]
Kubota, K. [1 ]
Gemma, A. [1 ]
机构：
[1] Nippon Med Sch, Grad Sch Med, Dept Pulm Med & Oncol, Tokyo, Japan
[2] Saitama Med Univ, Dept Resp Med, Int Med Ctr, Hidaka, Japan
[3] Nippon Med Sch, Musashikosugi Hosp, Dept Pulm Med, Kawasaki, Kanagawa, Japan
[4] Tokyo Metropolitan Canc & Infect Dis Ctr, Komagome Hosp, Dept Thorac Oncol & Resp Med, Tokyo, Japan
[5] Ishikawa Prefectural Cent Hosp, Dept Pulm Med, Kanazawa, Ishikawa, Japan
[6] Yokohama Municipal Citizens Hosp, Dept Resp Med, Yokohama, Kanagawa, Japan
[7] Tsuboi Canc Ctr Hosp, Jizankai Med Fdn, Dept Internal Med, Fukushima, Japan
[8] Nippon Med Sch, Chiba Hokuso Hosp, Dept Pulm Med, Chiba, Japan
[9] Jichi Med Univ, Dept Pulm Med, Shimotsuke, Tochigi, Japan
[10] Nippon Med Sch, Dept Pulm Med, Chiba Hokuso Hosp, Chiba, Japan
[11] Jichi Med Univ, Dept Pulm Med, Shimotsuke, Tochigi, Japan
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
445P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II study of efficacy of bevacizumab plus chemotherapy in management of malignant pleural effusion (MPE) in non-squamous non-small cell lung cancer (NSCLC) patients with MPE unsuccessfully controlled by tube drainage or pleurodesis (North East Japan Study Group Trial NEJ-013B-2).
    Noro, Rintaro
    Kobayashi, Kunihiko
    Usuki, Jiro
    Hosomi, Yukio
    Nishitsuji, Masaru
    Okamoto, Hiroaki
    Hino, Mitsunori
    Hagiwara, Koichi
    Miyanaga, Akihiko
    Seike, Masahiro
    Kubota, Kaoru
    Gemma, Akihiko
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] A phase II study of bevacizumab in non-squamous, non-small-cell lung cancer patients with malignant pleural effusion
    Wu Di
    Cong Yue
    Zhang Ziran
    Zhang Jie
    Nie Jun
    Dai Ling
    Hu Weiheng
    Chen Xiaoling
    Ma Xiangjuan
    Tian Guangming
    Han Jindi
    Han Sen
    Wang Yang
    Long Jieran
    Fang Jian
    FUTURE ONCOLOGY, 2022, 18 (06) : 669 - 677
  • [3] Bevacizumab plus chemotherapy for advanced non-squamous non-small-cell lung cancer with malignant pleural effusion
    Kitamura, Kazuhiro
    Kubota, Kaoru
    Ando, Masahiro
    Takahashi, Satoshi
    Nishijima, Nobuhiko
    Sugano, Teppei
    Toyokawa, Masaru
    Miwa, Koji
    Kosaihira, Seiji
    Noro, Rintaro
    Minegishi, Yuji
    Seike, Masahiro
    Yoshimura, Akinobu
    Gemma, Akihiko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (02) : 457 - 461
  • [4] Bevacizumab plus chemotherapy for advanced non-squamous non-small-cell lung cancer with malignant pleural effusion
    Kazuhiro Kitamura
    Kaoru Kubota
    Masahiro Ando
    Satoshi Takahashi
    Nobuhiko Nishijima
    Teppei Sugano
    Masaru Toyokawa
    Koji Miwa
    Seiji Kosaihira
    Rintaro Noro
    Yuji Minegishi
    Masahiro Seike
    Akinobu Yoshimura
    Akihiko Gemma
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 457 - 461
  • [5] Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B
    Norol, Rintaro
    Kobayashi, Kunihiko
    Usuki, Jiro
    Yomota, Makiko
    Nishitsuji, Masaru
    Shimokawa, Tsuneo
    Ando, Masahiro
    Hino, Mitsunori
    Hagiwara, Koichi
    Miyanaga, Akihiko
    Seike, Masahiro
    Kubota, Kaoru
    Gemma, Akihiko
    THORACIC CANCER, 2020, 11 (07) : 1876 - 1884
  • [6] Phase II study of bevacizumab in combination with carboplatin plus paclitaxel as first-line chemotherapy for non-squamous non-small cell lung cancer with malignant pleural effusion
    Tamiya, M.
    Tamiya, A.
    Asami, K.
    Okishio, K.
    Kawagchi, T.
    Suzuki, H.
    Okamoto, N.
    Kawase, I.
    Atagi, S.
    Hirashima, T.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S826 - S826
  • [7] PHASE II STUDY OF BEVACIZUMAB IN COMBINATION WITH CARBOPLATIN PLUS PACLITAXEL AS FIRST-LINE CHEMOTHERAPY FOR NON-SQUAMOUS NON-SMALL CELL LUNG CANCER WITH MALIGNANT PLEURAL EFFUSION
    Tamiya, Akihiro
    Tamiya, Motohiro
    Yamadori, Tadahiro
    Yasue, Tomomi
    Nakao, Keiko
    Shiroyama, Takayuki
    Asami, Kazuhiro
    Morishita, Naoko
    Suzuki, Hidekazu
    Okamoto, Norio
    Okishio, Kyoichi
    Kawaguchi, Tomoya
    Hirashima, Tomonori
    Atagi, Shinji
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1159 - S1160
  • [8] EFFICACY AND SAFETY OF CHEMOTHERAPY CONTAINING BEVACIZUMAB IN PATIENTS WITH NON-SMALL CELL LUNG CANCER WITH MALIGNANT PLEURAL EFFUSION
    Fujii, Mitsuhiro
    Iwakami, Shin-Ichiro
    Ihara, Hiroaki
    Hara, Munechika
    Iwakami, Naoko
    Ishiwata, Toshiji
    Takahashi, Kazuhisa
    RESPIROLOGY, 2013, 18 : 87 - 87
  • [9] The Efficacy of Pleurodesis on Non-Small-Cell Lung Cancer with Large Malignant Pleural Effusion
    Kimura, Madoka
    Naito, Tateaki
    Kenmotsu, Hirokazu
    Nakamura, Yukiko
    Tsuya, Asuka
    Kaira, Kyoichi
    Murakami, Haruyasu
    Takahashi, Toshiaki
    Endo, Masahiro
    Yamamoto, Nobuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S402 - S402
  • [10] Efficacy of bevacizumab through an indwelling pleural catheter in non-small cell lung cancer patients with symptomatic malignant pleural effusion
    Hao Zeng
    Yuanyuan Zhang
    Sihan Tan
    Qin Huang
    Xin Pu
    Panwen Tian
    Yalun Li
    BMC Pulmonary Medicine, 24
12345